GeneReach Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-110.28	-118.73	-166.27	221.34	376.62
Depreciation & Amortization	69.44	73.73	68.03	64.28	59.24
Other Amortization	1.66	1.01	0.86	0.89	0.77
Loss (Gain) From Sale of Assets	13.5	28.17	1.39	-1.7	-0.41
Loss (Gain) From Sale of Investments	9.05	2.57	2.5	3.7	3.81
Stock-Based Compensation	2.02	-	-	-	-
Provision & Write-off of Bad Debts	-7.05	-4.65	21.43	-1.13	5.06
Other Operating Activities	-11.72	-1.35	-66.17	-65.61	14.8
Change in Accounts Receivable	10.74	-16.97	12.04	138.08	-31.15
Change in Inventory	3.09	14.8	124.59	16.07	-91.29
Change in Accounts Payable	-0.9	1.39	-0.24	-6.04	-5.44
Change in Unearned Revenue	-0.67	-0.55	-2.84	-11.49	13.17
Change in Other Net Operating Assets	7.61	-2.63	-33.99	-0.73	3.82
Operating Cash Flow	-13.52	-23.22	-38.67	357.63	348.99
Operating Cash Flow Growth	-	-	-	2.48%	105.51%
Capital Expenditures	-6.36	-7.12	-23.53	-49.87	-19.56
Sale of Property, Plant & Equipment	0.83	0.17	-	3.93	1.97
Sale (Purchase) of Intangibles	-6.01	-1.34	-3.82	-0.59	-1.36
Investment in Securities	138.59	-62.75	-221.54	-	3.85
Other Investing Activities	-0.06	0.84	-1.02	-1.48	-26.61
Investing Cash Flow	127	-70.21	-249.91	-48.01	-41.7
Short-Term Debt Issued	259	137	55	-	-
Long-Term Debt Issued	-	-	-	-	198
Total Debt Issued	259	137	55	-	198
Short-Term Debt Repaid	-294	-70	-	-	-2
Long-Term Debt Repaid	-11.19	-47.58	-201.94	-19.35	-8.82
Total Debt Repaid	-305.19	-117.58	-201.94	-19.35	-10.82
Net Debt Issued (Repaid)	-46.19	19.42	-146.94	-19.35	187.18
Repurchase of Common Stock	-17.31	-	-	-	-
Common Dividends Paid	-	-	-	-208.94	-143.67
Other Financing Activities	-0.02	-15.99	-68.95	-	-0.04
Financing Cash Flow	-63.52	3.43	-215.89	-228.28	43.48
Foreign Exchange Rate Adjustments	-5.17	-16.5	-27.37	3.84	-1.01
Net Cash Flow	44.8	-106.5	-531.84	85.18	349.75
Free Cash Flow	-19.87	-30.35	-62.21	307.76	329.43
Free Cash Flow Growth	-	-	-	-6.58%	206.11%
Free Cash Flow Margin	-8.54%	-14.70%	-27.59%	41.03%	32.55%
Free Cash Flow Per Share	-0.35	-0.53	-1.08	5.19	5.62
Cash Interest Paid	6.64	5.54	4.56	4.58	5.26
Cash Income Tax Paid	6.28	5.4	14.03	117.39	78.3
Levered Free Cash Flow	-10.08	-68.75	22.55	262.91	331.25
Unlevered Free Cash Flow	-6.02	-65.04	26.15	267.04	335.16
Change in Working Capital	19.87	-3.96	99.56	135.88	-110.9

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.